Amring Pharmaceuticals Announces 2018/19 Launches

January 4, 2019 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it launched a generic oncology drug, Arsenic Trioxide Injection in November 2018 and expects to launch four (4) additional...
844.304.4828 More contact options
Products Partner Company LinkedIn
More news & events